291 related articles for article (PubMed ID: 8409422)
1. Characterization of a cell surface glycoprotein IPO-3, expressed on activated human B and T lymphocytes.
Sidorenko SP; Clark EA
J Immunol; 1993 Nov; 151(9):4614-24. PubMed ID: 8409422
[TBL] [Abstract][Full Text] [Related]
2. Antibody to a novel 95-kDa surface glycoprotein on human B cells induces calcium mobilization and B cell activation.
Valentine MA; Clark EA; Shu GL; Norris NA; Ledbetter JA
J Immunol; 1988 Jun; 140(12):4071-8. PubMed ID: 3259604
[TBL] [Abstract][Full Text] [Related]
3. Activation of human B cells. Comparison of the signal transduced by IL-4 to four different competence signals.
Clark EA; Shu GL; Lüscher B; Draves KE; Banchereau J; Ledbetter JA; Valentine MA
J Immunol; 1989 Dec; 143(12):3873-80. PubMed ID: 2480376
[TBL] [Abstract][Full Text] [Related]
4. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells.
Akiba H; Oshima H; Takeda K; Atsuta M; Nakano H; Nakajima A; Nohara C; Yagita H; Okumura K
J Immunol; 1999 Jun; 162(12):7058-66. PubMed ID: 10358148
[TBL] [Abstract][Full Text] [Related]
5. Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells.
Ware CF; Crowe PD; Grayson MH; Androlewicz MJ; Browning JL
J Immunol; 1992 Dec; 149(12):3881-8. PubMed ID: 1281193
[TBL] [Abstract][Full Text] [Related]
6. Induction of germinal center B cell markers in vitro by activated CD4+ T lymphocytes: the role of CD40 ligand, soluble factors, and B cell antigen receptor cross-linking.
Lahvis GP; Cerny J
J Immunol; 1997 Aug; 159(4):1783-93. PubMed ID: 9257841
[TBL] [Abstract][Full Text] [Related]
7. Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation.
Bougeret C; Mansur IG; Dastot H; Schmid M; Mahouy G; Bensussan A; Boumsell L
J Immunol; 1992 Jan; 148(2):318-23. PubMed ID: 1530858
[TBL] [Abstract][Full Text] [Related]
8. Leu 23 induction as an early marker of functional CD3/T cell antigen receptor triggering. Requirement for receptor cross-linking, prolonged elevation of intracellular [Ca++] and stimulation of protein kinase C.
Testi R; Phillips JH; Lanier LL
J Immunol; 1989 Mar; 142(6):1854-60. PubMed ID: 2466079
[TBL] [Abstract][Full Text] [Related]
9. A member of the tetra spans transmembrane protein superfamily is recognized by a monoclonal antibody raised against an HLA class I-deficient, lymphokine-activated killer-susceptible, B lymphocyte line. Cloning and preliminary functional studies.
Gil ML; Vita N; Lebel-Binay S; Miloux B; Chalon P; Kaghad M; Marchiol-Fournigault C; Conjeaud H; Caput D; Ferrara P
J Immunol; 1992 May; 148(9):2826-33. PubMed ID: 1573270
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies of IPO series against B cell differentiation antigens in leukemia and lymphoma immunophenotyping.
Sidorenko SP; Vetrova EP; Yurchenko OV; Berdova AG; Shlapatskaya LN; Gluzman DF
Neoplasma; 1992; 39(1):3-9. PubMed ID: 1528302
[TBL] [Abstract][Full Text] [Related]
11. A novel glycoprotein expressed on sheep T and B lymphocytes is involved in a T cell activation pathway.
Hein WR; McClure S; Beya MF; Dudler L; Trnka Z
J Immunol; 1988 May; 140(9):2869-75. PubMed ID: 2834446
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes.
Melero I; Salmerón A; Balboa MA; Aramburu J; López-Botet M
J Immunol; 1994 Feb; 152(4):1662-73. PubMed ID: 8120376
[TBL] [Abstract][Full Text] [Related]
13. A novel antigen (H47 Ag) on human lymphocytes involved in T cell activation.
Hirohashi N; Nakao M; Kubo K; Yamada A; Shichijo S; Hara A; Sagawa K; Itoh K
Cell Immunol; 1993 Dec; 152(2):371-82. PubMed ID: 8258145
[TBL] [Abstract][Full Text] [Related]
14. Cognate T cell help for CD40-deficient B cells induces c-myc RNA expression, but DNA synthesis requires an additional signal through surface Ig.
Schrader CE; Stavnezer J; Kikutani H; Parker DC
J Immunol; 1997 Jan; 158(1):153-62. PubMed ID: 8977186
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the human CD27 ligand, a novel member of the TNF gene family.
Hintzen RQ; Lens SM; Beckmann MP; Goodwin RG; Lynch D; van Lier RA
J Immunol; 1994 Feb; 152(4):1762-73. PubMed ID: 8120385
[TBL] [Abstract][Full Text] [Related]
16. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
17. [Monoclonal antibodies IPO-4 recognizing antigen-activated human T and B lymphocytes].
Sidorenko SP; Berdova AG; Vetrova EP; Shlapatskaia LN; Iurchenko OV; Evsev'eva AI; Gluzman DF
Eksp Onkol; 1990; 12(3):21-4. PubMed ID: 2344819
[TBL] [Abstract][Full Text] [Related]
18. Expression of a 33-kDa antigen Tm 1 on lymphocyte surface after modulation of cell surface antigens by IgM monoclonal antibody.
Hara T; Jung LK; Fu SM
J Immunol; 1988 Feb; 140(4):1028-33. PubMed ID: 2963858
[TBL] [Abstract][Full Text] [Related]
19. MLR3 molecule is an activation antigen shared by human B, T lymphocytes and T cell precursors.
Risso A; Cosulich ME; Rubartelli A; Mazza MR; Bargellesi A
Eur J Immunol; 1989 Feb; 19(2):323-8. PubMed ID: 2784767
[TBL] [Abstract][Full Text] [Related]
20. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
Hirohata S
Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
